Results 231 to 240 of about 231,458 (256)

High-throughput engineering of bispecific antibodies to enhance macrophage-mediated cytotoxicity of B-cell lymphoma. [PDF]

Nat Commun
Pagès-Geli C, Ribeiro J, Wienclaw T, Meglan AM, Sloat L, Silva M, Blandin J, Velarde J, Vaccaro K, Sebastiany C, Fernández-Guzmán P, Hahn CK, Crespo M, Weiskopf K.   +13 more
europepmc   +1 more source

Rituximab Binding Endows CD20+ Extracellular Vesicles With NK Cell-Activating Properties in B Cell Lymphoma. [PDF]

J Extracell Vesicles
Otero AV, Pérez PS, Gaete-Ramírez B, Cordini G, Norte M, Martínez E, Marsol N, Malusardi C, Rivarola S, Cantillo A, Leicaj ML, Russo C, Braghini JQ, Penas F, Ernst G, Cabral C, Palmer S, Varas-Godoy M, Arruvito L, Ostrowski M.   +19 more
europepmc   +1 more source

Do human B-1 lymphocytes truly exist? [PDF]

Front Immunol
Martínez-Gutiérrez MI, Cañedo-Solares I, Gómez-Chávez F, Molina-López LM, Flores-Rabasa R, Magdaleno-Villanueva JA, León-Pedroza JI, Correa D.   +7 more
europepmc   +1 more source

Chemoimmunotherapy‐associated CD20 (MS4A1) resistance mutations in Waldenström macroglobulinemia: Epitope disruption independent of expression with implications for CD20‐directed cellular therapies

HemaSphere, Volume 10, Issue 10, October 2026.
Alberto Guijosa, Nickolas Tsakmaklis, Sirano Dhe‐Paganon, Filip Garbicz, Ruben Carrasco, John Hatcher, Andres Ramirez‐Gamero, Dominic Pizzarella, Amanda Kofides, Shirong Liu, Hao Sun, Xia Liu, María L. Guerrera, Andrew R. Branagan, Gottfried von Keudell, Shayna R. Sarosiek, Jorge J. Castillo, Zachary R. Hunter, Steven P. Treon   +18 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CD20 as a gatekeeper of the resting state of human B cells

Proceedings of the National Academy of Sciences of the United States of America, 2021
Michael Reth, Sebastian N Steiner, Ulrich Salzer   +2 more
exaly  

CD20+ T cells: an emerging T cell subset in human pathology

Inflammation Research, 2022
Adrian Y. S. Lee
exaly  

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

Proceedings of the National Academy of Sciences of the United States of America, 2023
Fredrik Piehl, Martin S Weber, Tjalf Ziemssen   +2 more
exaly  

Development of an SPR-based binding assay for characterization of anti-CD20 antibodies to CD20 expressed on extracellular vesicles

Analytical Biochemistry, 2022
Yonglian Sun, James T Koerber, Yongmei Chen   +2 more
exaly